Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine

Clinical trial NCT01667341 · COMPLETED

Trial details

NCT number: NCT01667341
Sponsor: Genocea Biosciences, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Genital Herpes Simplex Type 2

Start date: 2012-07-01
Primary completion: 2014-05-09
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.